Mindstate Design Labs
Private Company
Making every therapeutically valuable emotion available on demand in pharmaceutical form
Biotechnology
San Francisco, California
2-10 employees
Founded 2021
About Mindstate Design Labs
Mindstate Design Labs is a biotechnology company addressing the mental health crisis by developing precision-designed psychedelic therapeutics. Leveraging its proprietary AI neuroengineering platform, Osmanthus, the company creates novel compounds like MSD-001 to induce specific emotional and cognitive states without hallucinations. Its primary customers are clinicians and health systems treating patients with treatment-resistant psychiatric disorders.
Company Classification
Customer Types
B2B
Business Models
ProductsLicensing
Product & Service Types
Psychedelic-inspired therapeuticsAI drug discovery platform
Funding
Total Funding
$24.32M
No. of Funding Rounds
4
Customers
| Customer | Success Story | Source |
|---|---|---|
| Conducted inaugural clinical trials on MSD-101 with 52 participants in the Netherlands. |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos